Pfizer Inc. (PFE) News Headlines

▮ More

Date

Headline

8/4/2021 7:13:41 AM Pfizer: Phase 2b/3 Ritlecitinib Trial Meets Primary Efficacy Endpoint In Alopecia Areata Patients

8/4/2021 6:47:44 AM Pfizer Announces Positive Top-line Results From Phase 2b/3 ALLEGRO Trial Of Ritlecitinib In Alopecia Areata

8/2/2021 9:16:43 AM Pfizer, Moderna Raise Vaccine Prices For EU

7/28/2021 7:48:39 AM Pfizer Lifts FY21 Outlook On Updated Covid Vaccine Expectations

7/28/2021 6:52:48 AM Pfizer Inc. (PFE) Has Raised Its FY21 Revenue Estimate To $78.0 to $80.0 Bln From $70.5 to $72.5 Bln

7/28/2021 6:52:25 AM Pfizer Inc. (PFE) Has Raised Its FY21 EPS Estimate To 3.95 - 4.05 From 3.55 - 3.65

7/28/2021 6:51:37 AM Pfizer Inc. Q2 adjusted earnings of $1.07 per share

7/28/2021 6:48:22 AM Pfizer Q2 Adj. EPS Rises To $1.07 From $0.62 Last Year

7/28/2021 6:47:23 AM Pfizer Q2 Reported EPS $0.98; Adj EPS $1.07

7/28/2021 6:00:10 AM Pfizer Q2 21 Earnings Conference Call At 10:00 AM ET

7/27/2021 7:47:32 AM Viatris : Mylan Wins Dismissal Of Kansas EpiPen Direct Purchaser Case

7/27/2021 1:45:55 AM Biotech Stocks Facing FDA Decision In August 2021

7/23/2021 7:08:27 AM Pfizer, BioNTech Say U.S. Government To Buy Addl 200 Mln Doses Of COVID-19 Vaccine - Quick Facts

7/23/2021 6:51:50 AM Pfizer, BioNTech: U.S. Government To Buy Addl 200 Mln Doses Of Pfizer-BioNTech COVID-19 Vaccine

7/22/2021 10:04:41 AM GSK : Brian McNamara Appointed As CEO Designate Of Independent Consumer Healthcare Company

7/22/2021 8:38:03 AM Pfizer, Arvinas Ink Deal To Develop And Commercialize PROTAC Protein Degrader ARV-471 - Quick Facts

7/22/2021 8:18:11 AM Arvinas And Pfizer Announce Global Collaboration To Develop PROTAC Protein Degrader ARV-471

7/21/2021 5:10:38 PM FDA Extends New Drug Application Of Pfizer's Abrocitinib, XELJANZ

7/21/2021 7:43:02 AM Pfizer, BioNTech Team With Biovac To Manufacture And Distribute COVID-19 Vaccine Within Africa

7/20/2021 4:11:56 AM Pfizer Recalls Anti-smoking Drug Chantix Tablets